{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:11:13Z","timestamp":1794478273213,"version":"4.9.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["UF1AG032438"],"award-info":[{"award-number":["UF1AG032438"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.neurobiolaging.2018.10.011","type":"journal-article","created":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T01:02:08Z","timestamp":1539392528000},"page":"42-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network"],"prefix":"10.1016","volume":"75","author":[{"given":"Aur\u00e9lie","family":"Bussy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Joy","family":"Snider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Coble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8114-0552","authenticated-orcid":false,"given":"Tammie L.S.","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2109-2955","authenticated-orcid":false,"given":"Brian A.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hassenstab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7729-1702","authenticated-orcid":false,"given":"Randall J.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biopsycho.2007.03.001","article-title":"The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades","volume":"75","author":"Alexander","year":"2007","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib3","doi-asserted-by":"crossref","first-page":"E4502","DOI":"10.1073\/pnas.1317918110","article-title":"Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease","volume":"110","author":"Benzinger","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib4","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuroimage.2004.06.018","article-title":"A\u00a0unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume","volume":"23","author":"Buckner","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib5","first-page":"41","article-title":"Genetics of Alzheimer's disease","volume":"25-26","author":"Burke","year":"1991","journal-title":"Int. J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/WNL.0b013e3182a841c6","article-title":"The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study","volume":"81","author":"Cash","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1212\/WNL.0000000000002939","article-title":"Gray matter maturation and cognition in children with different APOE epsilon genotypes","volume":"87","author":"Chang","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000109150","article-title":"Neuroimaging and APOE genotype: a systematic qualitative review","volume":"24","author":"Cherbuin","year":"2007","journal-title":"Dement Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib10","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/418932a","article-title":"Cognitive change and the APOE epsilon 4 allele","volume":"418","author":"Deary","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0197-4580(01)00271-8","article-title":"MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease","volume":"22","author":"Dickerson","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12933-016-0329-1","article-title":"Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease","volume":"15","author":"El-Lebedy","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jalz.2016.12.003","article-title":"Preclinical Alzheimer's disease: a systematic review of the cohorts underlying the concept","volume":"13","author":"Epelbaum","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.21559","article-title":"Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly","volume":"65","author":"Fagan","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib15","doi-asserted-by":"crossref","first-page":"226ra230","DOI":"10.1126\/scitranslmed.3007901","article-title":"Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease","volume":"6","author":"Fagan","year":"2014","journal-title":"Sci. Trans Med."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib16","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"issue":"Pt 6","key":"10.1016\/j.neurobiolaging.2018.10.011_bib17","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/brain\/119.6.2001","article-title":"Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study","volume":"119","author":"Fox","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib18","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/WNL.0000000000003234","article-title":"Relative effect of APOE epsilon 4 on neuroimaging biomarker changes across the lifespan","volume":"87","author":"Gonneaud","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib19","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1212\/WNL.0000000000004733","article-title":"Increased florbetapir binding in the temporal neocortex from age 20 to 60 years","volume":"89","author":"Gonneaud","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib20","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamaneurol.2016.2642","article-title":"Longitudinal beta-amyloid deposition and hippocampal volume in preclinical Alzheimer disease and suspected non-Alzheimer disease pathophysiology","volume":"73","author":"Gordon","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib21","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopsych.2010.05.013","article-title":"Progression of cerebral amyloid load is associated with the apolipoprotein E epsilon4 genotype in Alzheimer's disease","volume":"68","author":"Grimmer","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib22","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3174\/ajnr.A4805","article-title":"Relationship between APOE genotype and structural MRI measures throughout adulthood in the study of Health in Pomerania population-based cohort","volume":"37","author":"Habes","year":"2016","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J.\u00a0Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain beta-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib25","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1474-4422(14)70194-2","article-title":"Age-specific population frequencies of cerebral beta-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study","volume":"13","author":"Jack","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib27","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib28","doi-asserted-by":"crossref","first-page":"16265","DOI":"10.1523\/JNEUROSCI.2170-12.2012","article-title":"Region-specific hierarchy between atrophy, hypometabolism, and beta-amyloid (Abeta) load in Alzheimer's disease dementia","volume":"32","author":"La Joie","year":"2012","journal-title":"J.\u00a0Neurosci."},{"issue":"Pt 10","key":"10.1016\/j.neurobiolaging.2018.10.011_bib29","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1093\/brain\/aww200","article-title":"BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease","volume":"139","author":"Lim","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib30","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1007\/s12035-015-9388-7","article-title":"Multiple effect of APOE genotype on clinical and neuroimaging biomarkers across Alzheimer's disease spectrum","volume":"53","author":"Liu","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib31","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.4155\/cli.12.93","article-title":"Developing an international network for Alzheimer research: the dominantly inherited Alzheimer Network","volume":"2","author":"Morris","year":"2012","journal-title":"Clin. Investig."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib33","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archneurol.2009.269","article-title":"Pittsburgh Compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease","volume":"66","author":"Morris","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/alzrt213","article-title":"Dominantly Inherited Alzheimer Network: facilitating research and clinical trials","volume":"5","author":"Moulder","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jalz.2011.10.003","article-title":"Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults","volume":"8","author":"Paternico","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/WNN.0000000000000071","article-title":"Alzheimer Lesions in the autopsied brains of people 30 to 50 Years of age","volume":"28","author":"Pletnikova","year":"2015","journal-title":"Cogn. Behav. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-2010-100561","article-title":"Cerebrospinal fluid markers for Alzheimer's disease over the lifespan: effects of age and the APOEepsilon4 genotype","volume":"22","author":"Popp","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000071827","article-title":"The combined effects of apolipoprotein E polymorphism and low-density lipoprotein cholesterol on cognitive performance in young adults","volume":"48","author":"Puttonen","year":"2003","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib40","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","article-title":"Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein","volume":"334","author":"Reiman","year":"1996","journal-title":"E.\u00a0N. Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib41","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib42","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1073\/pnas.0500579102","article-title":"Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism","volume":"102","author":"Reiman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.410440226","article-title":"Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease","volume":"44","author":"Reiman","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neurobiolaging.2004.06.019","article-title":"Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study","volume":"26","author":"Riley","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib45","first-page":"904","article-title":"Correction for partial volume effects in PET: principle and validation","volume":"39","author":"Rousset","year":"1998","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib46","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian imaging, biomarkers and lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0197-4580(00)00229-3","article-title":"The levels of cerebrospinal fluid Abeta40 and Abeta42(43) are regulated age-dependently","volume":"22","author":"Shoji","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib48","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/clinchem\/47.10.1776","article-title":"Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values","volume":"47","author":"Sjogren","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib49","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/archneur.62.12.1821","article-title":"Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life","volume":"62","author":"Snider","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1037\/neu0000030","article-title":"Clinical and psychological characteristics of the initial cohort of the dominantly inherited Alzheimer network (DIAN)","volume":"28","author":"Storandt","year":"2014","journal-title":"Neuropsychology"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib51","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuroimage.2014.11.058","article-title":"Partial volume correction in quantitative amyloid imaging","volume":"107","author":"Su","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib53","doi-asserted-by":"crossref","first-page":"e73377","DOI":"10.1371\/journal.pone.0073377","article-title":"Quantitative analysis of PiB-PET with FreeSurfer ROIs","volume":"8","author":"Su","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib54","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jamaneurol.2015.1285","article-title":"Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age","volume":"72","author":"Sutphen","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib55","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(94)92557-7","article-title":"Protection against Alzheimer's disease with apoE epsilon 2","volume":"343","author":"Talbot","year":"1994","journal-title":"Lancet"},{"issue":"Pt 9","key":"10.1016\/j.neurobiolaging.2018.10.011_bib56","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/brain\/awv199","article-title":"Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects","volume":"138","author":"Toledo","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0887-6177(03)00039-8","article-title":"Trail Making Test A and B: normative data stratified by age and education","volume":"19","author":"Tombaugh","year":"2004","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3940(00)01789-4","article-title":"No association between apolipoprotein E polymorphisms and general cognitive ability in children","volume":"299","author":"Turic","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib60","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1212\/WNL.0b013e318288690c","article-title":"Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI","volume":"80","author":"Vos","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib61","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1212\/WNL.0000000000001903","article-title":"Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease","volume":"85","author":"Wang","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib62","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jalz.2016.11.007","article-title":"Recent publications from the Alzheimer's Disease Neuroimaging Initiative: reviewing progress toward improved AD clinical trials","volume":"13","author":"Weiner","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neurobiolaging.2009.02.003","article-title":"The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis","volume":"32","author":"Wisdom","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib64","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1203\/01.PDR.0000090927.53818.DE","article-title":"Apolipoprotein E genotype predicts 24-month bayley scales infant development score","volume":"54","author":"Wright","year":"2003","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neurobiolaging.2018.10.011_bib65","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0304-3940(00)01569-X","article-title":"Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers","volume":"294","author":"Yu","year":"2000","journal-title":"Neurosci. Lett."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018303750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018303750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T09:12:20Z","timestamp":1720689140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458018303750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":65,"alternative-id":["S0197458018303750"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.10.011","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}